Harald Bradl | Director Cell Culture Development
Boehringer Ingelheim Pharma GmbH & Co. KG

Harald Bradl, Director Cell Culture Development, Boehringer Ingelheim Pharma GmbH & Co. KG

Director Protein Science     
Bioprocess & Analytical Development Germany  
Responsible for the development of state-of-the-art purification processes for CMB client projects including process transfers to the global BioBU production network.
Responsible for driving project independent development (PID) and ensuring stringent implementation of novel technologies to continuously improve the downstream platform process.

Appearances:



Festival of Biologics Day 2 @ 14:20

Next generation downstream process development and manufacturing

  • High throughput process parameter screening to speed up development timeline
  • Downstream process intensification to increase facility utilization
  • CFD to support scale-up from small scale to final commercial scale
last published: 01/Jul/22 16:05 GMT

back to speakers